{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:43:26Z","timestamp":1790109806992,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ekir.2021.08.024","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T23:43:22Z","timestamp":1630712602000},"page":"2840-2849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Rituximab-Associated Flare of Cryoglobulinemic Vasculitis"],"prefix":"10.1016","volume":"6","author":[{"given":"Janina Paula T.","family":"Sy-Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charat","family":"Thongprayoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren P.","family":"Herrera Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Zoghby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2021.08.024_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-018-0009-4","article-title":"Cryoglobulinaemia","volume":"4","author":"Roccatello","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ekir.2021.08.024_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jbspin.2019.01.016","article-title":"Cryoglobulinemia: An update in 2019","volume":"86","author":"Desbois","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ekir.2021.08.024_bib3","doi-asserted-by":"crossref","first-page":"102313","DOI":"10.1016\/j.jaut.2019.102313","article-title":"New insights in cryoglobulinemic vasculitis","volume":"105","author":"Silva","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.ekir.2021.08.024_bib4","first-page":"3","article-title":"Cryoglobulinemia (review)","volume":"6","author":"Takada","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ekir.2021.08.024_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2016-09-719773","article-title":"How I treat cryoglobulinemia","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2021.08.024_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10157-008-0042-9","article-title":"Acute renal failure secondary to severe type 1 cryoglobulinemia following rituximab therapy for Waldenstrom\u2019s macroglobulinemia","volume":"12","author":"Shaikh","year":"2008","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2021.08.024_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajh.20207","article-title":"Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenstr\u00f6m macroglobulinemia does not indicate failure of response","volume":"77","author":"Ghobrial","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ekir.2021.08.024_bib8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/annonc\/mdh403","article-title":"Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom\u2019s macroglobulinemia","volume":"15","author":"Treon","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ekir.2021.08.024_bib9","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/cncr.20658","article-title":"Initial immunoglobulin M \u2018flare\u2019 after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia","volume":"101","author":"Ghobrial","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ekir.2021.08.024_bib10","doi-asserted-by":"crossref","unstructured":"Desbois AC, Biard L, S\u00e8ne D, et\u00a0al. Rituximab-associated vasculitis flare: incidence, predictors, and outcome. J Rheumatol. 2020;47:896\u2013902.","DOI":"10.3899\/jrheum.190076"},{"key":"10.1016\/j.ekir.2021.08.024_bib11","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1002\/art.25000","article-title":"Rituximab may form a complex with iGm\u03ba mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus\u2013induced vasculitis","volume":"60","author":"S\u00e8ne","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ekir.2021.08.024_bib12","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1002\/art.27666","article-title":"Rituximab-induced accelerated cryoprecipitation in hepatitis C virus\u2013associated mixed cryoglobulinemia has parallels with intravenous immunoglobulin\u2013induced immune complex deposition in mixed cryoglobulinemia: Comment on the article by S\u00e8ne et\u00a0al","volume":"62","author":"Misbah","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ekir.2021.08.024_bib13","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1002\/art.38798","article-title":"Induction of interleukin-6 production by rituximab in human B cells","volume":"66","author":"Jones","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ekir.2021.08.024_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood.V114.22.761.761","article-title":"The IgM flare following rituximab and IVIG administration in Waldenstrom's macroglobulinemia is related to IL-6 production by bystander immune cells, possibly through stimulation of the Fcgriia receptor","volume":"114","author":"Yang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2021.08.024_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/bjh.15232","article-title":"A\u00a0tale of two antibodies: obinutuzumab versus rituximab","volume":"182","author":"Freeman","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ekir.2021.08.024_bib16","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.3389\/fimmu.2019.03069","article-title":"Neutralizing anti-rituximab antibodies and relapse in membranous nephropathy treated with rituximab","volume":"10","author":"Boyer-Suavet","year":"2020","journal-title":"Front Immunol"},{"issue":"Suppl 129","key":"10.1016\/j.ekir.2021.08.024_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.55563\/clinexprheumatol\/rit83o","article-title":"Flare of a mixed cryoglobulinaemic vasculitis after obinutuzumab infusion","volume":"39","author":"Martin de Fremont","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ekir.2021.08.024_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2017.11.035","article-title":"an update on detection, mechanisms and clinical contribution","volume":"17","author":"Kolopp-Sarda","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ekir.2021.08.024_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.blre.2006.12.002","article-title":"Cryoglobulinemia","volume":"21","author":"Tedeschi","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.ekir.2021.08.024_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V69.2.677.677","article-title":"Characterization of monoclonal IgG cryoglobulins: fine-structural and morphological analysis","volume":"69","author":"Podell","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2021.08.024_bib21","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1097\/CM9.0000000000000325","article-title":"Cryoglobulinemic vasculitis and glomerulonephritis: concerns in clinical practice","volume":"132","author":"Chen","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ekir.2021.08.024_bib22","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/j.1756-185X.2011.01645.x","article-title":"Serum sickness and severe angioedema following rituximab therapy in RA","volume":"15","author":"Kumar","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.ekir.2021.08.024_bib23","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/annonc\/mdg488","article-title":"Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment","volume":"14","author":"Hellerstedt","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ekir.2021.08.024_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3816\/CLM.2009.n.026","article-title":"Waldenstr\u00f6m's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia","volume":"9","author":"Stone","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.ekir.2021.08.024_bib25","first-page":"227","article-title":"Studies of the hyperviscosity syndrome. II. Macroglobulinemia","volume":"85","author":"MacKenzie","year":"1975","journal-title":"J\u00a0Lab Clin Med"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921014091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921014091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:38:51Z","timestamp":1762832331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024921014091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2468024921014091"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2021.08.024","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab-Associated Flare of Cryoglobulinemic Vasculitis","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2021.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}